Myeloproliferative neoplasms (MPNs) are a leading cause of splanchnic vein thrombosis
(SVT). SVT is observed in all MPNs and frequently affects young patients. Therapy should …

Splanchnic vein thrombosis (SVT) in the setting of myeloproliferative neoplasm (MPN) is a
unique clinical entity that requires close interdisciplinary coordination for proper diagnosis …

Background Patients with chronic myeloproliferative neoplasms (MPNs), including essential
thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are at high …

Prefibrotic myelofibrosis (pre-PMF) is a distinct entity among chronic myeloproliferative
neoplasm diagnosed according to the revised 2016 WHO classification. The clinical picture …

专家简介: 郭涛, 华中科技大学同济医学院附属协和医院血液科主任医师, 博士生导师.
担任中国医师协会血液科医师分会委员, 海峡两岸医药卫生交流协会血液病学专业委员会副主任 …

Myeloproliferative neoplasms (MPN) show dysregulated JAK2 signaling. JAK2 inhibitors
provide clinical benefits, but compensatory activation of MAPK pathway signaling impedes …

Myeloproliferative neoplasms (MPNs) are a group of chronic hematologic malignancies that
lead to morbidity and early mortality due to thrombotic complications and progression to …

Introduction Polycythemia vera (PV), a Philadelphia chromosome-negative
myeloproliferative neoplasm, is characterized by panmyelosis, pancytosis, and a JAK2 …

Polycythemia vera (PV) is a chronic myeloproliferative neoplasm (MPN) characterized by
shortened survival due to potentially fatal complications including thrombosis, and …

Background Polycythemia vera (PV) and essential thrombocythemia (ET) are linked to
increased risk of cardiovascular morbidity and mortality. In addition to the reduction in of …